Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3Genitourinary 1

Conditions

Breast Neoplasms 3Rectal Neoplasms 1Prostatic Neoplasms 1Lung Neoplasms 1Glioblastoma 1Carcinoma 1Brain Neoplasms 1Advanced Breast Cancer 1

Interventions

Fulvestrant 125Trastuzumab 114Paclitaxel 113Letrozole 108pembrolizumab 79pertuzumab 75palbociclib 75Capecitabine 72Anastrozole 72Cyclophosphamide 70Carboplatin 67abemaciclib 64exemestane 63Tamoxifen 63ribociclib 60trastuzumab deruxtecan 57Surveys and Questionnaires 51Specimen Handling 50Radiotherapy 49Docetaxel 49Magnetic Resonance Spectroscopy 48Blood Specimen Collection 40olaparib 39Standard of Care 36Biopsy 33sacituzumab govitecan 31130-nm albumin-bound paclitaxel 31Doxorubicin 30Exercise 29eribulin 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasms × Lead × 1 year × Clear all
NCT01517945 2026-04-24

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

Memorial Sloan Kettering Cancer Center

Active not recruiting
252 enrolled
Breast

Breast Neoplasms

NCT07014618 2025-12-17

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

University of Oklahoma

Recruiting
420 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT06640881 2025-10-01

REPEAT

Amsterdam UMC, location VUmc

Phase 2 Recruiting
25 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡